ClinicalTrials.Veeva

Menu

The Effect of Myofascial Release Technique on Sportive Performance, Balance and Injury Risk in Runners

M

Medipol Health Group

Status

Unknown

Conditions

Runt

Treatments

Other: Myofascial therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05392153
E-10840098-772.02-2678

Details and patient eligibility

About

In order to investigate the effect of myofascial release technique on sportive performance, balance and injury risk in runners, 49 athletes will include in the study. The myofascial application group (n=26)will receive 12 sessions of 6-weekly lower extremity posterior muscle therapy. The control group (n=23) will continue the routine exercise program.

Full description

Running is a sport that involves repetitive movement and is particularly vulnerable to injury in the lower extremities. Myofascial release, on the other hand, is a manual method that is effective in increasing blood and oxygen permeability between tissues, renewing the tissue, protecting it from injury and increasing performance. The aim of our study is to investigate the effect of Myofascial application on sportive performance balance and injury risk in runners. The study will carry out on runners with a 3-month running history. Myofascial application group (n=26) and control group (n=23) will divide into two groups as randomized controlled. My Jump 2 App, Y balance test and Functional Movement Analysis (FMS) will use as assessment methods. The myofascial application group will receive 12 sessions of 6 weeks of therapy for the lower extremity posterior group muscles. The control group will continue the routine exercise program.

Enrollment

49 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Have a running history of more than 3 months
  • Be between 18 and 45 years old
  • Being a healthy individual without chronic disease
  • No acute injury affecting the lower extremity
  • Running at least 5 km a week
  • Willingness to participate in the research

Exclusion criteria

  • Pregnancy or suspected pregnancy
  • Use of alcohol or active substance
  • Having another ongoing treatment process
  • Having a history of surgery on the lower extremity
  • Refusal to participate in the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

49 participants in 2 patient groups

Myofascial therapy group
Experimental group
Description:
The myofascial therapy group (n=26) will receive 12 sessions of 6-weekly lower extremity posterior muscle myofascial therapy.
Treatment:
Other: Myofascial therapy
Control group
No Intervention group
Description:
The control group (n=23) will not receive lower extremity posterior muscle myofascial therapy. They will continue the routine exercise program.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems